The At1g04380 antibody (Product Code: CSB-PA309769XA01DOA) is a polyclonal antibody designed for detecting the protein product of the AT1G04380 gene. This gene encodes a member of the 2-oxoglutarate (2OG) and Fe(II)-dependent oxygenase superfamily, which is implicated in oxidative metabolic processes in plants .
The AT1G04380 gene product is part of a conserved enzyme family involved in:
Secondary metabolite biosynthesis (e.g., flavonoids, alkaloids) .
Regulation of plant growth and stress responses through oxidative modifications .
Iron-dependent catalytic activity, suggesting roles in redox homeostasis .
The At1g04380 antibody has been utilized in:
Protein localization studies to determine subcellular distribution in Arabidopsis tissues.
Functional genomics to characterize knockout mutants or overexpression lines.
Interaction studies with metabolic enzymes, such as ACCase (acetyl-CoA carboxylase), to explore regulatory networks in fatty acid synthesis .
Cross-reactivity: Specificity confirmed for Arabidopsis thaliana; no reported cross-reactivity with other plant species .
Validation: Antibody specificity verified via immunoblotting against recombinant protein and mutant controls .
Functional data gaps: Detailed mechanistic roles of AT1G04380 remain underexplored.
Potential extensions: CRISPR-based knockouts paired with antibody-based protein quantification could elucidate its metabolic contributions.
At1g04380 encodes a 2-oxoglutarate (2OG) and Fe(II)-dependent oxygenase superfamily protein in Arabidopsis thaliana. This protein family plays critical roles in various plant metabolic processes, including hormone biosynthesis, DNA repair, and stress responses. Developing antibodies against this protein allows researchers to study its expression patterns, subcellular localization, protein-protein interactions, and functional mechanisms. The antibodies serve as specific molecular probes that enable visualization and quantification of the protein in different experimental contexts, advancing our understanding of plant biology and stress responses.
Several antibody formats can be developed to target At1g04380 protein:
Polyclonal antibodies: Generated by immunizing animals (typically rabbits or goats) with purified At1g04380 protein or peptide fragments. These contain a heterogeneous mixture of antibodies recognizing different epitopes.
Monoclonal antibodies: Produced from single B-cell clones, offering higher specificity but typically requiring mouse or rat immunization followed by hybridoma technology.
Single domain antibodies (sdAbs): Derived from camelid species (e.g., llamas) which naturally produce heavy-chain-only antibodies. These smaller antibody fragments maintain high specificity while offering advantages in stability and tissue penetration .
Recombinant antibody fragments: Including Fab, scFv, or nanobodies engineered for specific research applications.
Each format has distinct advantages depending on the intended application, with considerations for specificity, affinity, and experimental compatibility.
Thorough validation is essential to ensure antibody specificity and reliability:
Western blot analysis: Comparing wild-type plants versus At1g04380 knockout/knockdown lines to verify absence/reduction of signal in mutant samples.
Immunoprecipitation followed by mass spectrometry: Confirming that the antibody captures the intended target protein.
Peptide competition assays: Pre-incubating the antibody with excess antigen peptide should abolish specific signal.
Cross-reactivity testing: Examining antibody binding to related plant proteins to assess specificity.
Binding kinetics characterization: Using techniques like Bio-Layer Interferometry (BLI) to determine affinity constants (KD, kon, koff) for the antibody-antigen interaction .
A properly validated At1g04380 antibody should show consistent results across multiple techniques and biological replicates with minimal non-specific binding.
Single domain antibodies (sdAbs) derived from camelids present several advantages for At1g04380 research:
Enhanced stability: sdAbs demonstrate remarkable thermal stability and resistance to harsh conditions, maintaining functionality under conditions that would denature conventional antibodies.
Improved tissue penetration: Their smaller size (12-15 kDa versus 150 kDa for conventional IgG) allows better penetration into plant tissues and cellular compartments.
Reduced aggregation: Less prone to aggregation, enabling higher concentration solutions for certain applications.
Versatile engineering: sdAbs can be readily engineered for various applications, including fusion to fluorescent proteins or attachment to various Fc regions to introduce specific effector functions .
Intracellular functionality: Unlike conventional antibodies, some sdAbs can function within the cytoplasm as "intrabodies," enabling new experimental approaches for tracking and modulating At1g04380 in living cells.
Research with tau proteins has demonstrated that unmodified sdAbs can effectively bind targets without toxicity while promoting clearance of target proteins . This suggests similar approaches could be valuable for plant protein research.
Successful immunoprecipitation (IP) of At1g04380 requires careful optimization:
Extraction buffer composition:
50 mM Tris-HCl (pH 7.5)
150 mM NaCl
1% Triton X-100 or NP-40
0.5% sodium deoxycholate
1 mM EDTA
Protease inhibitor cocktail
Phosphatase inhibitors (if studying phosphorylated forms)
Procedure optimization:
Pre-clearing step: Incubate plant lysate with protein A/G beads for 1 hour at 4°C to remove non-specific binding proteins.
Antibody incubation: Use 2-5 μg of antibody per 500 μg of total protein, incubate overnight at 4°C with gentle rotation.
Bead capture: Add 30-50 μl of protein A/G magnetic beads, incubate for 2-4 hours at 4°C.
Washing stringency: Typically 4-5 washes with decreasing salt concentrations to remove non-specific interactions while maintaining specific binding.
Elution method: Either low pH glycine buffer (0.1 M, pH 2.7) neutralized immediately with Tris buffer (pH 8.5) , or by boiling in SDS sample buffer.
The optimal conditions may vary depending on the specific antibody subclass and epitope targeted. For sdAbs that lack Fc regions, direct conjugation to beads or use of anti-tag antibodies may be required.
BLI provides valuable kinetic information about antibody-antigen interactions for At1g04380 research:
Experimental setup:
Sensor preparation: Hydrate anti-mouse IgG Fc Capture (AMC) probes or Ni-NTA probes (for His-tagged sdAbs).
Baseline establishment: Alternate 10 mM glycine and PBS-T for 20 seconds each to improve baseline stability.
Antibody loading: Load antibodies at 5 μg/ml for 120 seconds.
Association phase: Expose antibody-loaded sensors to varying concentrations of purified At1g04380 protein for 300 seconds.
Dissociation phase: Transfer to buffer-only wells for 400 seconds.
Controls: Include sensors with antibody but no antigen exposure.
Sensor regeneration: Alternate incubation with 10 mM glycine and PBS-T .
Data analysis:
Subtract measurements from blank probes
Use 1:1 binding model to fit curves
Analyze globally by fitting curves for multiple concentrations simultaneously
Calculate affinity constants (KD) and on/off rates (kon, koff)
This methodology enables precise comparison between different antibody formats (sdAbs vs. IgG subclasses) and assists in selecting the optimal antibody for specific applications based on binding kinetics.
Several approaches can improve At1g04380 antibody performance:
Fc engineering: Converting sdAbs to different IgG subclasses (IgG1, IgG2A, IgG2B, IgG3) by attachment to appropriate Fc regions, which can dramatically affect efficacy and functionality .
Affinity maturation: Using directed evolution or rational design to modify complementarity-determining regions (CDRs) for improved binding affinity and specificity.
Stability enhancement: Introducing disulfide bonds or charged residues to improve thermal and pH stability.
Format optimization:
For intracellular applications: Developing minimized formats like nanobodies or intrabodies
For in vivo imaging: Creating fusion proteins with fluorescent proteins
For detection sensitivity: Generating fusion proteins with enzymes like HRP or alkaline phosphatase
Expression system selection:
Each modification should be followed by comprehensive validation to ensure maintained specificity and appropriate functionality.
Rigorous controls ensure reliable immunohistochemistry results:
Essential controls:
Negative genetic control: Tissue from At1g04380 knockout/knockdown plants showing absence/reduction of signal.
Peptide competition: Pre-incubating antibody with immunizing peptide should eliminate specific staining.
Secondary antibody-only control: Omitting primary antibody to detect non-specific secondary antibody binding.
Isotype control: Using irrelevant antibody of same isotype/subclass to assess non-specific binding.
Overexpression control: Tissue from plants overexpressing At1g04380 should show increased signal intensity.
Experimental considerations:
Fixation optimization: Test multiple fixatives (4% paraformaldehyde, glutaraldehyde, methanol) to preserve epitope accessibility.
Antigen retrieval: Especially important for formalin-fixed tissues; citrate buffer (pH 6.0) or Tris-EDTA (pH 9.0) at 95-98°C.
Blocking optimization: 5-10% normal serum from the species of secondary antibody production, plus 1-3% BSA.
Antibody titration: Test multiple dilutions to determine optimal signal-to-noise ratio.
Counterstaining: Include DAPI for nuclei and additional markers for subcellular compartments to enhance spatial information.
Consistent application of these controls allows confident interpretation of At1g04380 localization patterns.
When encountering non-specific binding, systematic troubleshooting is necessary:
Western blot issues:
Increase blocking stringency: Try 5% milk with 1% BSA in TBS-T, or switch to casein-based blockers.
Optimize antibody concentration: Perform titration series to identify minimal effective concentration.
Increase wash stringency: More frequent/longer washes with higher detergent concentration (0.1-0.3% Tween-20).
Add competing proteins: Including 5% normal serum from the host species of secondary antibody production.
Reduce exposure time: Overexposed blots may reveal minor non-specific binding.
Immunohistochemistry issues:
Tissue permeabilization optimization: Test different detergent concentrations and incubation times.
Pre-adsorption: Incubate antibody with plant extract from At1g04380 knockout plants to remove antibodies binding to other proteins.
Change detection system: Switch between avidin-biotin, polymer-based, or direct fluorescent conjugates.
Tissue-specific autofluorescence reduction: Using Sudan Black B (0.1-0.3%) or sodium borohydride treatment.
General approaches:
Antibody purification: Affinity purification against the immunizing antigen.
Alternative antibody format: If a polyclonal shows high background, try monoclonal or sdAb alternatives.
Epitope analysis: Consider whether the targeted epitope has homology to other plant proteins .
Multiple complementary approaches can reveal At1g04380 interaction partners:
Co-immunoprecipitation (Co-IP):
Standard Co-IP: Use At1g04380 antibody to pull down the protein complex, then identify partners by western blot or mass spectrometry.
Reverse Co-IP: Use antibodies against suspected interaction partners to confirm bidirectional interaction.
Crosslinking-assisted IP: Employ membrane-permeable crosslinkers like DSP or formaldehyde to stabilize transient interactions before lysis.
Proximity-based methods:
Proximity Ligation Assay (PLA): Visualize protein interactions in situ when proteins are within 40 nm.
BioID or TurboID: Fuse biotin ligase to At1g04380 to biotinylate proximal proteins, then capture with streptavidin and identify by mass spectrometry.
Binding assays:
ELISA-based binding assays: Immobilize purified At1g04380 and test binding of potential partners.
Surface Plasmon Resonance or Bio-Layer Interferometry: Measure real-time binding kinetics between At1g04380 and partners .
Important considerations:
Extraction conditions must preserve native protein complexes
Detergent selection is critical (typically start with 0.5-1% NP-40 or Digitonin)
Include appropriate controls (IgG isotype, knockout/knockdown samples)
Consider cell compartment-specific fractionation if interactions are compartment-specific
These methods can be used sequentially to build confidence in identified interaction networks.
At1g04380 antibodies enable sophisticated analysis of stress-induced protein modifications:
Experimental approaches:
Time-course analysis: Quantify At1g04380 protein levels at different time points after stress treatment using western blot with densitometry analysis.
Phosphorylation state analysis: Use phospho-specific At1g04380 antibodies to track stress-induced post-translational modifications.
Subcellular relocalization tracking: Employ immunofluorescence microscopy to monitor potential stress-induced changes in At1g04380 localization.
Chromatin immunoprecipitation (ChIP): If At1g04380 functions in transcriptional regulation, use antibodies to identify stress-responsive genomic binding sites.
Protein complex remodeling: Use co-immunoprecipitation with At1g04380 antibodies followed by mass spectrometry to identify stress-dependent changes in interaction partners.
Experimental design considerations:
Include multiple stress treatments (drought, salt, cold, heat, pathogens)
Compare responses in different plant tissues and developmental stages
Correlate protein levels with transcript abundance using RT-qPCR
Include genetic controls (knockout/overexpression lines)
This multi-faceted approach can reveal how At1g04380 contributes to plant stress adaptation mechanisms.
Intracellular antibodies (intrabodies) present unique challenges and opportunities:
Selection criteria:
Stability in reducing environments: Intracellular environment lacks oxidizing conditions needed for disulfide bond formation, so sdAbs that rely on disulfide bonds for stability may be ineffective.
Expression efficiency: Select constructs that express well in plant cells without aggregation or toxicity.
Target epitope accessibility: Choose epitopes that remain accessible in the native protein conformation within cellular compartments.
Subcellular targeting: Include appropriate targeting sequences for directing the intrabody to relevant compartments (nuclear localization signal, chloroplast transit peptide, etc.).
Delivery methods:
Transient expression: Agrobacterium-mediated transformation or protoplast transfection for rapid testing.
Stable transformation: For long-term studies of intrabody effects on plant development.
Viral vectors: For rapid systemic expression in mature plants.
Functional validation:
Knockdown phenotype: Effective intrabodies should produce phenotypes similar to genetic knockdowns if they block protein function.
Protein interaction disruption: Verify through Co-IP that the intrabody disrupts specific protein-protein interactions.
Live cell imaging: Fuse fluorescent proteins to intrabodies to track both the antibody and target localization .
Researchers should be aware that bivalent antibody binding might stabilize certain protein conformations, potentially affecting protein function in unexpected ways, as observed with certain tau-targeting antibodies .
Precise quantification requires careful methodology:
Western blot quantification:
Sample preparation standardization: Equal loading verified by housekeeping proteins and total protein staining (Ponceau S).
Standard curve inclusion: Include a dilution series of purified recombinant At1g04380 protein.
Linear range determination: Perform pilot experiments to identify the linear detection range for both primary antibody and detection method.
Replication: Minimum of three biological replicates and two technical replicates.
Analysis software: Use specialized software (ImageJ, Image Lab) for densitometry with background subtraction.
ELISA development:
Capture antibody: Use purified anti-At1g04380 antibody at 1-10 μg/ml.
Detection system: Biotinylated detection antibody (targeting different epitope) with streptavidin-HRP or direct HRP conjugate.
Standard curve: 7-8 point curve using purified recombinant At1g04380 protein.
Sample dilution optimization: Test multiple dilutions to ensure readings fall within the standard curve.
Immunohistochemistry quantification:
Standardized image acquisition: Fixed exposure settings, consistent microscope parameters.
Internal reference inclusion: Co-stain with markers of known abundance.
Digital image analysis: Use automated algorithms for unbiased quantification of signal intensity and colocalization.
These approaches enable reliable comparison of At1g04380 expression across different experimental conditions, tissues, or genotypes.
Advanced imaging applications offer new insights into At1g04380 dynamics:
Antibody format considerations:
Size and penetration: Single domain antibodies (12-15 kDa) have superior tissue penetration compared to full IgG (150 kDa) .
Fluorophore conjugation: Direct labeling with small fluorophores (Alexa Fluor, DyLight) or fusion to fluorescent proteins.
Binding kinetics: Fast on-rates and appropriate affinity to capture dynamic processes without disrupting function .
Specificity: Extremely high specificity is essential to minimize background in complex cellular environments.
Delivery strategies:
Cell-penetrating peptide conjugation: Enhance uptake using peptides like TAT or Penetratin.
Nanoparticle encapsulation: Protect antibody during delivery while enhancing uptake.
Microinjection: Direct delivery into specific cells for precise localization studies.
Transgenic expression: Generate plants expressing fluorescently-tagged intrabodies.
Advanced imaging applications:
FRET sensors: Engineer antibody-based Förster Resonance Energy Transfer pairs to detect At1g04380 conformational changes or interactions.
Single-molecule tracking: Use bright, photostable fluorophores to track individual At1g04380 molecules in living cells.
Super-resolution microscopy: Apply techniques like STORM or PALM using photoconvertible fluorophore-labeled antibodies.
Optogenetic control: Combine antibodies with light-sensitive domains to enable spatial and temporal control of At1g04380 function.
These approaches enable unprecedented visualization of At1g04380 dynamics in response to developmental cues or environmental stimuli.
Emerging technologies may translate At1g04380 research into agricultural innovations:
Diagnostic applications:
Field-deployable immunoassays: Developing lateral flow or microfluidic devices using At1g04380 antibodies to rapidly assess plant stress status.
Multiplex diagnostics: Creating antibody arrays to simultaneously monitor multiple stress-related proteins including At1g04380.
Early stress detection: Using highly sensitive antibody-based sensors to detect subtle changes in At1g04380 before visible symptoms appear.
Crop improvement tools:
Protein engineering guidance: Antibody epitope mapping to identify critical functional domains for targeted genetic modification.
Selection markers: Using antibody-based quantification of At1g04380 as a marker for stress tolerance in breeding programs.
Functional genomics: High-throughput antibody-based phenotyping to characterize gene-edited crops with modified At1g04380.
Advanced delivery systems:
Nanocarrier-antibody conjugates for targeted delivery of crop protection compounds.
Transgenic expression of stress-responsive intrabodies to modulate At1g04380 function under specific conditions.
These applications represent the translational potential of basic At1g04380 antibody research into practical agricultural solutions.
Creating a versatile antibody toolkit requires strategic planning:
Format diversity:
Multiple antibody formats targeting different epitopes:
Application-specific variants:
Western blot optimized formats
Immunoprecipitation-validated antibodies
Immunohistochemistry-specific formulations
Live-cell compatible versions
Validation standards:
Genetic controls: Testing in knockout, knockdown, and overexpression lines
Cross-reactivity profiling: Testing against related proteins and across plant species
Application-specific validation: Demonstrating performance in each intended application
Reproducibility testing: Multi-laboratory validation
Distribution considerations:
Documentation: Comprehensive protocols for each application
Stability testing: Establishing shelf-life under different storage conditions
Quality control: Lot-to-lot consistency testing
Open science: Considering open-source antibody development platforms
A well-designed antibody toolkit enables standardized, reproducible research across the plant science community while accelerating discovery around At1g04380 function.